This comprehensive overview explores the critical landscape of CRISPR-Cas delivery methods specifically tailored for sensitive primary cells, including immune cells (T-cells, NK cells), stem cells, and neurons.
This comprehensive guide for researchers and drug developers details the application of lipid nanoparticles (LNPs) for CRISPR-Cas delivery in mouse models.
For CRISPR-Cas therapies to achieve their full clinical potential, overcoming host immune recognition is a critical hurdle.
This article provides a comprehensive analysis of the primary challenges and innovative solutions for delivering CRISPR-Cas systems to target cells and tissues in vivo and ex vivo.
This comprehensive guide for researchers, scientists, and drug development professionals details CRISPR-Cas technology, from its foundational biology to advanced clinical applications.
This comprehensive review for researchers, scientists, and drug development professionals analyzes the state of CRISPR-based clinical trials for genetic disorders in 2025.
This article provides a comprehensive 2025 analysis of the rapidly evolving CRISPR-Cas clinical trial landscape for researchers and drug development professionals.
This article provides a comparative analysis for research and drug development professionals of CRISPR-Cas9 gene editing versus its evolved counterpart, CRISPR base editing.
This article provides a comprehensive overview of CRISPR base editing, a revolutionary gene-editing technology that enables precise nucleotide conversions without creating double-strand DNA breaks (DSBs).
This article provides a detailed, current overview of CRISPR base editing technologies for precise correction of point mutations.